GENE ONLINE|News &
Opinion
Blog

Amyotrophic Lateral Sclerosis
Trials & Approvals BiogenAmyotrophic Lateral Sclerosis
FDA Grants Biogen’s Ultra-Rare ALS Med Accelerated Approval
2023-04-26
Trials & Approvals Amyotrophic Lateral Sclerosis
Biogen’s Tofersen May Show Clinical Benefit in ALS Patients with Rare SOD1 Mutations
2023-03-21
Innovation Amyotrophic Lateral Sclerosis
Harvard’s Soft Robotic Wearable Device Helps ALS Patients Regain Arm Mobility
2023-02-09
R&D Amyotrophic Lateral Sclerosis
Repairing Genetic Mutations in Neurological Diseases with RNA Targeting Strategy
2022-11-25
Trials & Approvals Amyotrophic Lateral Sclerosis
Biogen’s ALS Drug Fails to Attain Primary Endpoint but Offers Hope With Secondary Outcomes
2021-10-18
Startups AAV
Setting its Sights on Neurological Disorders, CRISPR Therapeutics Turns to an AAV Startup That Just Emerged Out of Stealth
2021-06-16
Trials & Approvals RIPK1
Lilly to Expand Foothold in the Billion-Dollar Autoimmune and Inflammatory Disease Market with this New Collaboration
2021-02-20
Trials & Approvals Amyotrophic Lateral Sclerosis
Brainstorm’s Stem Cell Therapy Flunks Phase 3 ALS Trial
2020-11-20
Technology CRISPR
Scribe, Biogen Partner to Combat ALS using Nobel Prize-Winning CRISPR Technology
2020-10-08
R&D
Altering the Treatment Landscape of Neurodegenerative Diseases Using Antisense Oligonucleotides (ASOs)
2020-08-17
R&D
Merck and Yumanity Sign $500 Million Deal to Develop ALS and FTLD Treatments
2020-06-26
LATEST
Bio Asia Pacific 2024 Close ASEAN Collaborations: Catalyzing Innovation and Global Partnerships
2024-09-12
Illumina’s IVD Biomarker Test Becomes the First FDA-approved Pan-cancer Companion Diagnostics Kit
2024-09-11
Lotus Pharma Expands in Southeast Asia with Alpha Choay Acquisition from Sanofi
2024-09-06
Indian CDMO Stocks in the Spotlight: US House to Vote on BIOSECURE Act Next Week
2024-09-06
Eli Lilly Joins Forces with AI Startup Genetic Leap in $409M Deal Centered Around RNA-Targeted Drug Discovery
2024-09-06
Illumina Wins EU Court Battle, Dodges Fine, but Grail Deal Already Void
2024-09-05
Breaking New Ground for Clinical Trials with AI/ML Applications
2024-09-05
READ MORE
EVENT
2024-09-13
ESMO Congress 2024
Barcelona, Spain
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-10
BioJapan / Regenerative Medicine Japan / healthTECH JAPAN 2024
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top